Kimia Biosciences share news, announcements and annual reports
BSE: 530313Pharmaceuticals & BiotechnologySmall Cap
KIMIA BIOSCIENCES LIMITED · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1995
Last close ₹30.45up ₹0.20 (0.66%)
Share price at the BSE close on 29 Oct 2026. Previous close ₹30.25.
29 Oct: open ₹30.00, high ₹30.90, low ₹30.00
52-week range of traded prices to 29 Oct 2026
₹23.20Low, 30 Mar 2026₹43.28High, 16 Feb 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹144 Cr2,580th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 20.05
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 8.13
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 51.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 19.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 1.95
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 2
Kimia Biosciences has 546 announcements on record, routine notices left out; none in the 30 days to 29 Oct 2026, the latest on 29 Sep 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Kimia Biosciences quarterly results
Aug10Mon
The board met on 10 Aug 2026 to consider quarterly results
Notice filed 3 Aug 2026
Kimia Biosciences annual reports, presentations and earnings calls
The company's own documents, latest first.Kimia Biosciences financials, year by year
Annual reports25
- Annual report, year to Mar 20264 Sep 2026
- Annual report, year to Mar 20256 Sep 2025
- Annual report, year to Mar 202424 Jun 2025
- Annual report, year to Mar 20239 Sep 2023
- Annual report, year to Mar 20227 Sep 2022
20 earlier reports
- Annual report, year to Mar 20212 Sep 2021
- Annual report, year to Mar 20206 Sep 2020
- Annual report, year to Mar 20195 Sep 2019
- Annual report, year to Mar 201812 Oct 2018
- Annual report, year to Mar 201716 Oct 2017
- Annual report, year to Mar 201619 Oct 2016
- Annual report, year to Mar 201416 Mar 2016
- Annual report, year to Mar 201514 Mar 2016
- Annual report, year to Mar 2013Filing day not known
- Annual report, year to Mar 2012Filing day not known
- Annual report, year to Mar 2011Filing day not known
- Annual report, year to Mar 2010Filing day not known
- Annual report, year to Mar 2009Filing day not known
- Annual report, year to Mar 2008Filing day not known
- Annual report, year to Mar 2007Filing day not known
- Annual report, year to Mar 2006Filing day not known
- Annual report, year to Mar 2005Filing day not known
- Annual report, year to Mar 1999Filing day not known
- Annual report, year to Mar 1998Filing day not known
- Annual report, year to Mar 1997Filing day not known
Kimia Biosciences merger and demerger filings
Filings about a merger, demerger or scheme of arrangement, latest first.
Kimia Biosciences share news and announcements
Newest first. Page 1 of 11.
Sep 2026
Aug 2026
10 Aug · Results
3 Aug · Board meeting
Meeting on 10 Aug 2026: quarterly results
May 2026
20 May · Board meeting
Meeting on 29 May 2026: audited results
Apr 2026
27 Apr · Management
13 Apr · Legal
Exchange has sought clarification from Kimia Biosciences Ltd on April 13, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....4 Apr · Management
Mar 2026
23 Mar · Meeting
Feb 2026
19 Feb · Management
18 Feb · Meeting
14 Feb · Results
10 Feb · Non-Applicability Of Opening Of Suspense Escrow Account In Connection With Municipal Bond
10 Feb · Intimation Under Regulation 30 Of SEBI(Listing Obligations And Disclosure Requirements) Regulations,2015 -Granted A Patent For Improved 'Process For The Preparation Of 'Luliconazole' For 20 Years
9 Feb · Board meeting
Meeting on 14 Feb 2026: quarterly results
Jan 2026
Dec 2025
31 Dec · Management
29 Dec · Announcement Under Regulation 30 Of SEBI(Listing Obligation And Disclosure Requirements)Regulations 2015.
2 Dec · Board meeting
Meeting on 2 Dec 2025
Nov 2025
10 Nov · Board meeting
Meeting on 14 Nov 2025: quarterly results
Oct 2025
Sep 2025
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.
- 30 Sep 2026Board or managers changedup 0.06%+0.2 pts vs Nifty 500market median 0.0% · five sessions +4.6% (+4.8 pts vs Nifty 500) · volume 0.6× usual · The announcement
- 3 Aug 2026Board or managers changedup 0.22%−1.2 pts vs Nifty 500market median 0.0% · five sessions −5.3% (−6.4 pts vs Nifty 500) · volume 0.1× usual · The announcement
- 28 Apr 2026Board or managers changeddown 3.52%−3.3 pts vs Nifty 500market median 0.0% · five sessions −6.5% (−6.5 pts vs Nifty 500) · volume 0.3× usual · The announcement
- 20 Apr 2026Board or managers changeddown 3.90%−3.9 pts vs Nifty 500market median 0.0% · five sessions −2.6% (−1.3 pts vs Nifty 500) · volume 0.4× usual · The announcement
- 6 Apr 2026Board or managers changedup 5.12%+3.9 pts vs Nifty 500market median 0.0% · five sessions +33.4% (+26.7 pts vs Nifty 500) · volume 0.1× usual · The announcement
- 20 Feb 2026Board or managers changedup 2.67%+2.3 pts vs Nifty 500market median 0.0% · five sessions +1.2% (+0.6 pts vs Nifty 500) · volume 0.3× usual · The announcement
- 3 Feb 2026Board or managers changedup 6.60%+3.9 pts vs Nifty 500market median 0.0% · five sessions +8.7% (+5.0 pts vs Nifty 500) · volume 0.4× usual · The announcement
- 7 Jan 2026Board or managers changeddown 4.38%−4.4 pts vs Nifty 500market median 0.0% · five sessions −7.9% (−5.7 pts vs Nifty 500) · volume 4.7× usual · The announcement
- 31 Dec 2025Board or managers changedup 6.69%+5.8 pts vs Nifty 500market median 0.0% · five sessions +6.9% (+5.4 pts vs Nifty 500) · volume 3.8× usual · The announcement
- 12 Nov 2025Board or managers changedup 0.20%−0.5 pts vs Nifty 500market median 0.0% · five sessions +11.0% (+10.4 pts vs Nifty 500) · volume 0.2× usual · The announcement
15 earlier announcements
- 18 Aug 2025Board or managers changeddown 4.31%−5.4 pts vs Nifty 500market median 0.0% · five sessions −13.8% (−15.2 pts vs Nifty 500) · volume 2.1× usual · The announcement
- 24 Apr 2025Board or managers changeddown 0.97%−0.7 pts vs Nifty 500market median 0.0% · five sessions −10.6% (−9.6 pts vs Nifty 500) · volume 0.2× usual · The announcement
- 21 Apr 2025Board or managers changedup 2.46%+1.0 pts vs Nifty 500market median 0.0% · five sessions −1.9% (−2.7 pts vs Nifty 500) · volume 0.4× usual · The announcement
- 17 Sep 2024Order receivedup 1.68%+1.7 pts vs Nifty 500market median +1.1% · five sessions −3.6% (−5.3 pts vs Nifty 500) · volume 7.4× usual · The announcement
- 13 Aug 2024Board or managers changedup 3.00%+3.9 pts vs Nifty 500market median 0.0% · five sessions +6.7% (+5.1 pts vs Nifty 500) · volume 0.2× usual · The announcement
- 3 Jun 2024Board or managers changedup 4.99%+1.7 pts vs Nifty 500market median 0.0% · five sessions +8.4% (+5.3 pts vs Nifty 500) · volume 5.5× usual · The announcement
- 2 Apr 2024Board or managers changedup 0.81%+0.4 pts vs Nifty 500market median 0.0% · five sessions −1.6% (−3.2 pts vs Nifty 500) · volume 0.1× usual · The announcement
- 7 Sep 2023Board or managers changedup 0.21%−0.4 pts vs Nifty 500market median 0.0% · five sessions −0.6% (−2.0 pts vs Nifty 500) · volume 1.7× usual · The announcement
- 13 Feb 2023Board or managers changedup 0.64%+1.4 pts vs Nifty 500market median 0.0% · five sessions −10.2% (−10.1 pts vs Nifty 500) · volume 0.6× usual · The announcement
- 16 Aug 2022Board or managers changeddown 0.26%−1.2 pts vs Nifty 500market median 0.0% · five sessions −1.5% (−0.6 pts vs Nifty 500) · volume 0.3× usual · The announcement
- 31 May 2022Board or managers changeddown 8.48%−8.2 pts vs Nifty 500market median 0.0% · five sessions −8.0% (−7.3 pts vs Nifty 500) · volume 3.6× usual · The announcement
- 1 Oct 2021Board or managers changedup 2.24%+2.5 pts vs Nifty 500market median 0.0% · five sessions −0.2% (−1.8 pts vs Nifty 500) · volume 0.6× usual · The announcement
- 20 Sep 2021Board or managers changedup 2.56%+3.9 pts vs Nifty 500market median 0.0% · five sessions −0.8% (−1.9 pts vs Nifty 500) · volume 0.3× usual · The announcement
- 27 Aug 2018Board or managers changeddown 4.93%−6.0 pts vs Nifty 500market median 0.0% · five sessions −13.0% (−14.4 pts vs Nifty 500) · volume 0.3× usual · The announcement
- 19 Sep 2016Board or managers changed0.00%−0.8 pts vs Nifty 500market median 0.0% · five sessions 0.0% (−1.3 pts vs Nifty 500) · volume 2.2× usual · The announcement
Figures filed again
Lines the company later filed with a different value, rupee lines in ₹ crore and per-share lines in rupees.
| Line | Period | Accounts | First filed | Filed again | Change. The value filed again less the value first filed, as a per cent of the first. | First filed on | Filed again on |
|---|---|---|---|---|---|---|---|
| Dealing with a related party in the period | Quarter to Mar 2026 | Standalone | 3.78 | 10.58 | +179.9% | 29 May 2026 | 30 May 2026 |
| Net profit | Quarter to Jun 2018 | Standalone | 1.36 | 0.40 | −70.5% | 21 Aug 2018 | 14 Nov 2018 |
| Change in stock held | Quarter to Jun 2018 | Standalone | 2.27 | 2.56 | +12.9% | 21 Aug 2018 | 14 Nov 2018 |
| Profit before one-off items and tax | Quarter to Jun 2018 | Standalone | 1.36 | 0.40 | −70.5% | 21 Aug 2018 | 14 Nov 2018 |
| Net profit from continuing businesses | Quarter to Jun 2018 | Standalone | 1.36 | 0.40 | −70.5% | 21 Aug 2018 | 14 Nov 2018 |
| Total comprehensive income | Quarter to Jun 2018 | Standalone | 1.36 | 0.40 | −70.7% | 21 Aug 2018 | 14 Nov 2018 |
| Revenue from operations | Quarter to Jun 2018 | Standalone | 21.83 | 22.16 | +1.5% | 21 Aug 2018 | 14 Nov 2018 |
| Segment revenue | Quarter to Jun 2018 | Standalone | 21.83 | 22.17 | +1.5% | 21 Aug 2018 | 14 Nov 2018 |
| Segment profit before tax and finance costs | Quarter to Jun 2018 | Standalone | 1.36 | 0.40 | −70.5% | 21 Aug 2018 | 14 Nov 2018 |
| Segment finance costs | Quarter to Jun 2018 | Standalone | 0.19 | 0.27 | +42.8% | 21 Aug 2018 | 14 Nov 2018 |